MAPT and early-onset autosomal dominant Alzheimer disease: While synergy between proteins has been described previously (particularly for Alzheimer’s disease between amyloid-beta and tau [27] and potentially involving prion-proteins as well [27]), our data support the concept that the net effect of expressing two pathogenic proteins within the nervous system, even if such proteins are expressed in different cell types, is a synergistic increase in pathology.